Becton, Dickinson and Company Appoints Greg Rodetis as Senior Vice President of Investor Relations
Rodetis will also continue to serve as the company's treasurer.
Global medical technology company Becton, Dickinson and Company (BD) announced that it has appointed Gred Rodetis as senior vice president of investor relations.
Rodetis will also continue to serve in his role as treasurer.
In a press release, BD chief financial officer and executive vice president Chris DelOrefice said, “Greg's deep knowledge of BD, coupled with his expertise of the capital markets and existing relationships with the investment banking community, make him well-positioned to lead our investor relations function and serve as a valued partner to this important stakeholder group as BD continues to deliver on its growth strategy.”
SOURCE
(October 17, 2023); BD (Bection, Dickinson and Company); BD Names Greg Rodetis as Senior Vice President of Investor Relations; https://www.prnewswire.com/news-releases/bd-names-greg-rodetis-as-senior-vice-president-of-investor-relations-301958983.html
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
